Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018
October 17 2018 - 5:48PM
Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic
testing solutions and life science raw materials will report fourth
quarter and full year 2018 financial results Thursday, November 8,
2018.
Jack Kenny, Chief Executive Officer, Melissa Lueke, Chief
Financial Officer, and Eric Rasmussen, Corporate Development, will
host a conference call beginning at 9:00 a.m. Eastern Time to
discuss the results and answer questions. During the
conference call, the company will also introduce key elements of
its business strategy, as well as discuss other business and
financial developments.
To participate in the live call by telephone from the U.S., dial
(866) 443-5802, or from outside the U.S., dial (513) 360-6924, and
enter the audience pass code 2238529.
A replay will be available for 14 days beginning at 12:00 p.m.
Eastern Time on November 8, 2018 by dialing (855) 859-2056 and
entering pass code 2238529.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic products. We are dedicated to developing and delivering
better solutions that give answers with speed, accuracy and
simplicity that are redefining the possibilities of life from
discovery to diagnosis. Through discovery and development, we
provide critical life science raw materials used in immunological
and molecular tests for human, animal, plant, and environmental
applications. Through diagnosis, we provide diagnostic solutions in
areas including gastrointestinal and upper respiratory infections
and blood lead level testing. We build relationships and
provide solutions to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Jack KennyChief Executive
OfficerMeridian Bioscience, Inc.Phone: 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Apr 2023 to Apr 2024